Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray vs Intravenous Infusion for Recovery after Laparoscopic Cholecystectomy
ChiCTR2600119543Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in cholecystitis and cholelithiasis (3 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: 24-h quality of recovery. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
cholecystitischolelithiasis
Beyond the preview
Go deeper on ChiCTR2600119543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119543.